<E.g. <E.g. versus <E.g. <E.g. <E.g. 4075> <E.g. 14 <E.g. Jan Study ibuprofen in adults Germany, Randomised days> 2005> ABC> with mild USA, Chile> postoperative pain Phase III> Further safety/efficacy studies Studies in special populations (e.g. paediatric, elderly) Annex 5 - Synopsis of on-going and completed pharmacoepidemiological study programme Research Study Population & Duration of Milestones & Status Study question design study size follow up dates Choose one of the following: Planned Protocol under development Protocol agreed Data collection started Data collection ended Study completed
<E.g. Study ABC> <E.g. versus ibuprofen in adults with mild postoperative pain Phase III> <E.g. Germany, USA, Chile> <E.g. Randomised <E.g. 4075> <E.g. 14 days> <E.g. Jan 2005> Further safety/efficacy studies Studies in special populations (e.g. paediatric, elderly) Annex 5 - Synopsis of on-going and completed pharmacoepidemiological study programme Study Research question Study design Population & study size Duration of follow up Milestones & dates Status Choose one of the following: Planned Protocol under development Protocol agreed Data collection started Data collection ended Study completed
RMP_template.docx